Full Text
A Systematic Review of Pharmacoeconomic Evaluation of Erlotinib in The First-Line Treatment of Advanced Non-Small Cell Lung Cancer

Abstract

Authors

TT Nguyen I Grappasonni TB Nguyen F Petrelli

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×